Happy New Year To all InMed investors, wishing you a prosperous year. Looking closely at the Cannabis sector (&related), I predict that the big winners will be US MSOs, Village Farms and Cannabinoid Biosynthetic companies. InMed is the only NASDAQ traded biosynthetic company and has an incredible valuation. Market cap is low and share float is low. They haven't made as much noise as Willow and others (long quiet period due to IPO), but it's certainly the best play in this space. Their partner Almac has the supply chain they need as well access to 25 of the largest pharma companies in the world (does Willow have that?). I fully expect news in January (letter to shareholders, INM-755-102 update, scale-up at Almac progress, investment reports etc.). Good luck to all.